Goldman Sachs Group Inc Medical Devices

Goldman Sachs Group Inc

$596 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CERS Cerus Corp	$243M	$2.11 Million 0.0% of portfolio	1,520,882	Q1 2025 Reduced 4.38%
INGN Inogen Inc	$153M	$2.03 Million 0.0% of portfolio	284,180	Q1 2025 Added 16.86%
VREX Varex Imaging Corp	$313M	$1.75 Million 0.0% of portfolio	150,738	Q1 2025 Reduced 31.36%
BFLY Butterfly Network, Inc.	$320M	$1.72 Million 0.0% of portfolio	756,426	Q1 2025 Added 4.12%
DCTH Delcath Systems, Inc.	$99.3M	$1.57 Million 0.0% of portfolio	123,487	Q1 2025 Added 58.74%
CVRX Cv Rx, Inc.	$172M	$1.55 Million 0.0% of portfolio	126,906	Q1 2025 Reduced 13.4%
BVS Bioventus Inc.	$400M	$1.49 Million 0.0% of portfolio	162,412	Q1 2025 Added 19.15%
ZIMV Zim Vie Inc.	$267M	$1.44 Million 0.0% of portfolio	133,611	Q1 2025 Added 2.33%
RCEL Avita Medical, Inc.	$136M	$1.36 Million 0.0% of portfolio	167,039	Q1 2025 Reduced 4.81%
LUNG Pulmonx Corp	$115M	$1.32 Million 0.0% of portfolio	196,499	Q1 2025 Reduced 19.32%
NNOX Nano X Imaging Ltd.	$265M	$1.11 Million 0.0% of portfolio	221,891	Q1 2025 Reduced 31.07%
ARAY Accuray Inc	$127M	$855,000 0.0% of portfolio	477,906	Q1 2025 Reduced 2.78%
MYO Myomo, Inc.	$14.6M	$795,000 0.0% of portfolio	165,444	Q1 2025 Reduced 9.91%
MXCT Maxcyte, Inc.	$219M	$783,000 0.0% of portfolio	286,828	Q1 2025 Reduced 44.74%
ANIK Anika Therapeutics, Inc.	$164M	$781,000 0.0% of portfolio	51,984	Q1 2025 Reduced 24.32%
ELMD Electromed, Inc.	$161M	$770,000 0.0% of portfolio	32,281	Q1 2025 Added 9.02%
LNSR Lensar, Inc.	$146M	$546,000 0.0% of portfolio	38,680	Q1 2025 New
NPCE Neuro Pace Inc	$226M	$420,000 0.0% of portfolio	34,226	Q1 2025 Reduced 19.05%
SENS Senseonics Holdings, Inc.	$261M	$404,000 0.0% of portfolio	612,534	Q1 2025 Added 26.18%
QIPT Quipt Home Medical Corp.	$72.9M	$403,000 0.0% of portfolio	173,037	Q1 2025 Reduced 25.17%
MASS 908 Devices Inc.	$214M	$334,000 0.0% of portfolio	74,656	Q1 2025 Reduced 71.75%
SGHT Sight Sciences, Inc.	$169M	$232,000 0.0% of portfolio	96,790	Q1 2025 Reduced 32.49%
LUCD Lucid Diagnostics Inc.	$44.7M	$128,000 0.0% of portfolio	86,302	Q1 2025 Added 35.75%
NMTC Neuroone Medical Technologies Corp	$12.6M	$83,000 0.0% of portfolio	98,573	Q1 2025 New
CTSO Cytosorbents Corp	$44.9M	$62,000 0.0% of portfolio	62,662	Q1 2025 Added 149.22%
ICAD Icad Inc	$98M	$44,000 0.0% of portfolio	21,533	Q1 2025 New
CODX Co Diagnostics, Inc.	$9.46M	$4,000 0.0% of portfolio	13,006	Q1 2025 Reduced 18.67%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.